VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Tarsus Pharmaceuticals, Inc. (TARS) Total Return Calculator with Dividends Reinvested

Tarsus Pharmaceuticals, Inc.

Popular:

The total return for Tarsus Pharmaceuticals, Inc. (TARS) stock is +35.08% over the past 12 months. So far it's down 20.81% this year. The 5-year total return is +113.34%, meaning $10,000 invested in TARS stock 5 years ago would be worth $21,334 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in TARS 1 year ago, it would be worth $13,568 today — you'd have gained $3,568.

With Dividends Reinvested$13,568+35.68%

Price Only (No DRIP)$13,568+35.68%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in TARS

1Y$13,508+$3,508 (+35.1%)35.1% CAGR

3Y$41,026+$31,026 (+310.3%)60.1% CAGR

5Y$21,334+$11,334 (+113.3%)16.4% CAGR

10Y$31,079+$21,079 (+210.8%)12.0% CAGR

15Y$31,079+$21,079 (+210.8%)7.9% CAGR

20Y$31,079+$21,079 (+210.8%)5.8% CAGR

30Y$31,078+$21,078 (+210.8%)3.9% CAGR

Tarsus Pharmaceuticals, Inc. did not pay dividends during this period. Total return = price return.

Loading TARS total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-20.81%	—	-20.81%	—	$7,919
1Y	+35.08%	35.08%	+35.08%	—	$13,508
3Y	+310.26%	60.09%	+310.26%	—	$41,026
5Y	+113.34%	16.36%	+113.34%	—	$21,334
10Y	+210.79%	12.01%	+210.79%	—	$31,079
15Y	+210.79%	7.85%	+210.79%	—	$31,079
20Y	+210.79%	5.83%	+210.79%	—	$31,079
30Y	+210.78%	3.85%	+210.78%	—	$31,078

Risk & Highlights

Best Year+174.65%2024

Worst Year-46.19%2021

Max Drawdown-26.47%2025-12-24 → 2026-04-29

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-6.50%	-6.50%	—	+0.41%	-6.9pp
2025	+48.47%	+48.47%	—	+16.64%	+31.8pp
2024	+174.65%	+174.65%	—	+24.00%	+150.7pp
2023	+40.43%	+40.43%	—	+24.81%	+15.6pp
2022	-39.62%	-39.62%	—	-19.95%	-19.7pp

TARS outperformed the S&P 500 by 4.71pp over the past year (+35.08% vs +30.37%).

Loading summary...

TARS Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
TARSTarsus Pharmaceuticals, Inc.	$2.7B	-7.0%	-20.8%	+35.1%	—	+310.3%	+113.3%	+210.8%
LNTHLantheus Holdings, Inc.	$5.9B	+16.5%	+35.3%	+13.1%	—	-4.0%	+314.2%	+4192.5%
NUVLNuvalent, Inc.	$7.5B	+0.1%	+1.5%	+53.5%	—	+171.2%	+446.1%	+446.1%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
AEYEAudioEye, Inc.	$100M	+29.6%	-18.7%	-27.9%	—	+20.6%	-60.2%	+102.2%
RXSTRxSight, Inc.	$239M	-14.2%	-44.1%	-61.1%	—	-70.1%	-63.7%	-63.7%
AVXLAnavex Life Sciences Corp.	$289M	+1.3%	-15.2%	-63.2%	—	-62.9%	-72.4%	-25.7%
INVAInnoviva, Inc.	$1.9B	-2.1%	+14.7%	+21.7%	—	+95.2%	+94.4%	+94.9%
SGHTSight Sciences, Inc.	$286M	+51.1%	-29.3%	+85.0%	—	-49.7%	-84.2%	-84.2%
ALCOAlico, Inc.	$316M	-5.5%	+12.7%	+42.5%	+0.7pp	+82.3%	+45.6%	+66.6%
MCKMcKesson Corporation	$92.1B	-12.2%	-8.5%	+4.6%	+0.4pp	+106.4%	+286.9%	+348.1%

Compare:TARS vs LNTH TARS vs NUVL TARS vs PRAX TARS vs LNTH vs NUVL

About TARS Dividend Returns

Tarsus Pharmaceuticals, Inc. (TARS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of TARS over the past year?

Tarsus Pharmaceuticals, Inc. (TARS) delivered a return of 35.08% over the past year. Since TARS does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in TARS be worth today?

A $10,000 investment in Tarsus Pharmaceuticals, Inc. one year ago would be worth $13,508 today, representing a gain of $3,508.

Q3Does TARS pay dividends?

Tarsus Pharmaceuticals, Inc. (TARS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TARS, the total return equals the price-only return.

Q4Did TARS beat the S&P 500?

Yes, Tarsus Pharmaceuticals, Inc. (TARS) outperformed the S&P 500 by 4.71 percentage points over the past year. TARS delivered a total return of 35.08%, compared to the S&P 500's 30.37%. This 4.71pp alpha means investors in TARS earned more than a passive S&P 500 index fund.

Q5What is TARS's worst drawdown?

Tarsus Pharmaceuticals, Inc. (TARS) experienced a maximum drawdown of -26.47% over the past year, declining from its peak on 2025-12-24 to its trough on 2026-04-29. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is TARS's long-term total return over 10, 20, or 30 years?

Here are Tarsus Pharmaceuticals, Inc. (TARS)'s long-term returns with dividends reinvested. Over 10 years, the total return is 210.8% (12.0% CAGR) — $10,000 would have grown to $31,079. Over 20 years: 210.8% total return (5.8% CAGR) — $10,000 → $31,079. Over 30 years: 210.8% total return (3.9% CAGR) — $10,000 → $31,078. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was TARS's best and worst year?

Tarsus Pharmaceuticals, Inc.'s best calendar year was 2024 with a total return of 174.7%. Its worst year was 2021 with a total return of -46.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 220.8 percentage points.